Divis' Laboratories Share Price
(DIVISLAB)
₹5726.4▲0.42%
as on 04:01PM, 25 Feb 2025
Divis' Laboratories Performance
Day's Low
Day's High
₹5,664.8Day's Price Range₹5,774.352 Week's Low
52 Week's High
₹3,35052-Week Price Range₹6,285.45
| Returns % | |
| 1 Month Return | + 2.68 % |
| 3 Month Return | -5.7 % |
| 1 Year Return | + 60.07 % |
| Market Stats | |
| Previous Close | ₹5,702.55 |
| Open | ₹5,701.00 |
| Volume | 1.88L |
| Upper Circuit | - |
| Lower Circuit | - |
| Market Cap | ₹1,52,017.93Cr |
Divis' Laboratories Key Statistics
P/E Ratio
73.56
PEG Ratio
2.86
Market Cap
₹1,52,017.93 Cr
P/B Ratio
6.75
EPS
60.38
Dividend Yield
0.87
Sector
Pharmaceuticals
ROE
12.04
Divis' Laboratories Mutual Fund Holdings
Divis' Laboratories Analyst Rating
based on 28 analysts
35.71%
Buy
21.43%
Hold
42.86%
Sell
Based on 28 analysts offering long term price targets for Divis' Laboratories. An average target of ₹5845.75
Source: S&P Global Market Intelligence
Divis' Laboratories Share analysis
Divis' Laboratories price forecast by 28 analysts
Upside of2.08%
High
₹7400
Target
₹5845.75
Low
₹4118
Divis' Laboratories target price ₹5845.75, a slight upside of 2.08% compared to current price of ₹5726.4. According to 28 analysts rating.
Excluding Excise Duty and Other Income, represents Net Revenue
Divis' Laboratories revenue growth forecast
Expected growth rate Q1, FY2027:63.64%
Forecast
Actual
Including amortisation and stock based compensations
Divis' Laboratories EPS growth forecast
EPS estimate Q1, FY2027:106.09%
Forecast
Actual
Source: S&P Global Market Intelligence
Key events for Divis Laboratories Ltd
Divis Labs Shares Drop Following SBI Mutual Fund Stake Sale - 21 Feb, 2025
Divis Laboratories' shares fell nearly 4% after SBI Mutual Fund reduced its stake by selling 1,40,560 shares. The fund's holding decreased from 5.1005% to 5.0476%. Despite this decline, Divis Labs has seen a 55.6% increase in stock price over the past year.Macquarie Sets Target Price for Divis Laboratories - 19 Feb, 2025
Macquarie has initiated coverage on Divis Laboratories, setting a target price of ₹7,400, indicating significant growth potential in its custom synthesis business by FY30.Divis Laboratories Stock Rises for Third Consecutive Session - 13 Feb, 2025
Divis Laboratories Ltd shares increased by 2.08%, marking the third straight session of gains. The stock is currently priced at Rs 6093.9, up 63.83% over the past year, outperforming both NIFTY and Nifty Pharma index. The stock has also gained 1.73% in the last month, with trading volume exceeding the monthly average.Divis Laboratories Shares Decline Amid Concerns - 10 Feb, 2025
Divis Laboratories Ltd experienced a decline of over 3% in share price, closing at Rs 5,937.1, influenced by concerns over tariffs and high valuations.Divis Laboratories Continues Upward Trend - 06 Feb, 2025
Divis Laboratories Ltd gained 0.38% today, marking its fifth consecutive session of increases. The stock is up 64.71% over the past year, outperforming both the NIFTY and Nifty Pharma indices. Despite a slight decline in benchmark indices, Divis Laboratories shows strong performance with a 4.04% rise in the last month.Mixed Analyst Ratings for Divis Laboratories - 05 Feb, 2025
Divis Laboratories received varied analyst ratings, with ICICI Securities recommending a sell at Rs 4,500, while KR Choksey suggests accumulating at Rs 6,435. Motilal Oswal maintains a neutral stance with a target of Rs 6,200.Divis Laboratories Reports Strong Q3 Earnings Growth - 03 Feb, 2025
Divis Laboratories announced a robust Q3 performance with a 65% increase in net profit to Rs 589 crore and a 25% rise in revenue to Rs 2,319 crore. The company also commenced operations at its Kakinada project and reappointed CEO Kiran S Divi for another five years.Divis Laboratories Stock Shows Resilience Amid Market Sell-off - 27 Jan, 2025
Divis Laboratories Ltd is recommended to buy at ₹5,762, with a target price of ₹5,820-5,850 and a stop loss at ₹5,700. The stock is showing strength by holding support in a major demand zone despite broader market sell-offs, indicating potential for a pullback and further gains.
Insights on Divis Laboratories Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTBest in 1 Year
In the last 1 year, DIVISLAB has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
- POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 3 quarters, 430.0 Cr → 589.0 Cr (in ₹), with an average increase of 14.6% per quarter
- POSITIVE IMPACT
Price Rise
In the last 1 month, DIVISLAB stock has moved up by 2.7%
- POSITIVE IMPACT
FII Holding Up
Foreign Institutions have increased holdings from 17.25% to 17.99% in Dec 2024 quarter
NO EFFECTPromoter Holding Unchanged
Promoters holdings remained unchanged at 51.89% of holdings in Dec 2024 quarter
- NO EFFECT
Against Peers
In the last 3 years, Torrent Pharmaceuticals Ltd has given 120.5% return, outperforming this stock by 86.2%
NEGATIVE IMPACTMF Holding Down
Mutual Funds have decreased holdings from 11.92% to 11.89% in Dec 2024 quarter
- NEGATIVE IMPACT
Retail Holding Down
Retail Investor have decreased holdings from 9.80% to 9.59% in Dec 2024 quarter
- NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 2 quarters, 2.44K Cr → 2.40K Cr (in ₹), with an average decrease of 1.8% per quarter
News
FMCG Giants Collaborate with Startups to Adapt to Quick Commerce
Godrej Consumer Products, for example, had designed Cinthol foam body wash and Park Avenue gift sets to be sold on quick-commerce platforms. It has also graduated from despatching small packs to be sold on these quick-delivery platforms to selling larger variants, such as 3-litre laundry liquid bottles rather than 1-litre packs. Compared to last year, Godrej Consumer Products has seen a 2 times increase in quick commerce (sales), said Krishna Khatwani, head of sales (India), Godrej Consumer Products.22 Feb, 2025 05:30 AM5 Stocks to Buy: Varun Beverages, ICICI Bank, Godrej Consumer, and More
The analysts have chosen this stock for a target of Rs 1,675. This means the stock can provide up to 56 per cent returns from its last closing price.21 Feb, 2025 01:47 PMBrokerage Recommendations Impacting Stocks on February 20, 2025
CLSA on Godrej Consumer Products: Upgraded to Hold, target price of ₹1,015.20 Feb, 2025 09:12 AMDivis' Laboratories Financials
Index Inclusions
Divis' Laboratories Shareholding Pattern
| Investors | Holdings % | FY Quarter | 3M change |
|---|---|---|---|
| Promoter Holdings | 51.89% | 0.00 | |
| Foreign Institutions | 17.99% | 4.26 | |
| Mutual Funds | 11.89% | ||
| Retail Investors | 9.59% | ||
| Others | 8.65% |
Divis' Laboratories Key Indicators
Divis' Laboratories Valuation
Divis' Laboratories in the last 5 years
Lowest (28.97x)
November 21, 2022
Industry (50.89x)
February 25, 2025
Today (73.56x)
February 25, 2025
Highest (90.48x)
December 4, 2024
Divis' Laboratories Earnings and Dividends
Divis Laboratories Ltd Earnings Results
Divis Laboratories Ltd’s net profit jumped 64.53% since last year same period to ₹589Cr in the Q3 2024-2025. On a quarterly growth basis, Divis Laboratories Ltd has generated 15.49% jump in its net profits since last 3-months.
Read More about Earnings ResultsDivis Laboratories Ltd Dividends May,2024
In the quarter ending March 2024, Divis Laboratories Ltd has declared dividend of ₹30 - translating a dividend yield of 0.52%.
Read More about Dividends
Divis' Laboratories Technicals Summary
Bearish
Neutral
Bullish
Divis Laboratories Ltd is currently in a Bearish trading position according to technical analysis indicators.
Divis' Laboratories Peer Comparison
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
|---|---|---|---|---|---|---|
| HOLD | ₹1,52,017.93 Cr | 33.47% | 0.50 | ₹1,600 Cr | ₹7,845 Cr | |
| BUY | ₹1,02,579.90 Cr | 33.86% | 0.67 | ₹1,656 Cr | ₹10,727 Cr | |
| BUY | ₹38,563.27 Cr | 1.5% | 0.58 | ₹1,297 Cr | ₹14,755 Cr | |
| HOLD | ₹26,325.68 Cr | -2.44% | 0.50 | ₹772 Cr | ₹5,664 Cr | |
| BUY | ₹1,18,182.20 Cr | 49.32% | 0.50 | ₹4,155 Cr | ₹25,774 Cr |
About Divis' Laboratories
Divis Laboratories Ltd's top products include APIs and intermediates for anti-infectives, cardiovascular, central nervous system, anti-diabetics, gastro-intestinal and anti-inflammatory treatments. The company is also a leader in the manufacture of custom synthesis and process development services for the global pharmaceutical industry.
Divis Laboratories Ltd is the proud owner of several popular brands, including Divis Life, Divis Pharma and Divis Health. Divis Life offers a range of health and wellness products, while Divis Pharma provides a wide range of APIs, intermediates and custom synthesis services.
Share Price: ₹5726.40 per share as on 25 Feb, 2025 04:01 PM
Market Capitalisation: ₹1,52,017.93Cr as of today
Revenue: ₹2,319.00Cr as on December 2024 (Q4 24)
Net Profit: ₹589.00Cr as on December 2024 (Q4 24)
Listing date: 12 Mar, 2003
Chairperson Name: Ramesh B V Nimmagadda
| Organisation | Divis' Laboratories |
| Headquarters | Hyderabad |
| Industry | Pharmaceuticals |
| E-voting on shares | Click here to vote |
FAQs on Divis Laboratories Ltd
What is Divis Laboratories Ltd price today?
Divis Laboratories Ltd share price today stands at ₹5726.4, Open: ₹5701, Previous Close: ₹5702.55, High: ₹5774.3, Low: ₹5664.8, 52 Week High: ₹6285.45, 52 Week Low: ₹3350.
How to Buy Divis Laboratories Ltd Share in India?
- Get a PAN card
- Open a Demat account
- Open a Trading account
- Link your Demat account to your Trading account
- Fund your Trading account
- Place an order to buy Divis Laboratories Ltd shares
Is Divis Laboratories Ltd listed on NSE?
Divis Laboratories Ltd is listed on NSE
Is Divis Laboratories Ltd listed on BSE?
Divis Laboratories Ltd is listed on BSE
What are today's High and Low prices of Divis Laboratories Ltd?
- Today's highest price of Divis Laboratories Ltd is ₹5774.3.
- Today's lowest price of Divis Laboratories Ltd is ₹5664.8.
What are today's traded volumes of Divis Laboratories Ltd?
Today's traded volume of Divis Laboratories Ltd(DIVISLAB) is 1.88L.
What is today's market capitalisation of Divis Laboratories Ltd?
Today's market capitalisation of Divis Laboratories Ltd(DIVISLAB) is ₹152017.93Cr.
What is the 52 Week High and Low Range of Divis Laboratories Ltd?
How much percentage Divis Laboratories Ltd is down from its 52 Week High?
Divis Laboratories Ltd (DIVISLAB) share price is ₹5726.4. It is down -8.89% from its 52 Week High price of ₹6285.45
How much percentage Divis Laboratories Ltd is up from its 52 Week low?
Divis Laboratories Ltd (DIVISLAB) share price is ₹5726.4. It is up 70.94% from its 52 Week Low price of ₹3350
What are the historical returns of Divis Laboratories Ltd?
What is the PE ratio of Divis Laboratories Ltd today?
PE Ratio of Divis Laboratories Ltd is 73.56
PE ratio = Divis Laboratories Ltd Market price per share / Divis Laboratories Ltd Earnings per share